2 days ACRS Stock Up on Licensing Deal With Biosion for Two Immunology DrugsZacks
Aclaris stock surges on inking an exclusive license agreement with Biosion for global rights to two of the latter’s pipeline candidates, BSI-045B and BSI-502.
XAclaris stock surges on inking an exclusive license agreement with Biosion for global rights to two of the latter’s pipeline candidates, BSI-045B and BSI-502.
X